Original Research
Published on 27 May 2022
FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.783564
- 3,019 views
- 5 citations
Volumes
5,919 Publications
Original Research
Published on 09 May 2022
Multifocal Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIA/DIG): An Institutional Series Report and a Clinical Summary of This Rare Tumor
Frontiers in Oncology
doi 10.3389/fonc.2021.608129
- 2,907 views
- 4 citations
Systematic Review
Published on 04 Apr 2022
Meta-Analysis of Shrinkage Mode After Neoadjuvant Chemotherapy for Breast Cancers: Association With Hormonal Receptor
Frontiers in Oncology
doi 10.3389/fonc.2021.617167
- 4,032 views
- 3 citations
Original Research
Published on 04 Apr 2022
Baseline Mutations and Up-Regulation of PI3K-AKT Pathway Serve as Potential Indicators of Lack of Response to Neoadjuvant Chemotherapy in Stage II/III Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.784985
- 4,055 views
- 8 citations
Original Research
Published on 24 Mar 2022
Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage Ⅰ-Ⅲ Breast Cancer Receiving Chemotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.782383
- 2,873 views
- 9 citations
Original Research
Published on 17 Mar 2022
Comparison of the Detection Rates of Different Diagnostic Methods for Primary Peripheral Lung Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.696239
- 2,207 views
- 5 citations
Original Research
Published on 11 Mar 2022
Functions, Roles, and Biological Processes of Ferroptosis-Related Genes in Renal Cancer: A Pan-Renal Cancer Analysis
Frontiers in Oncology
doi 10.3389/fonc.2021.697697
- 5,644 views
- 7 citations
Original Research
Published on 09 Mar 2022
A-Kinase Interacting Protein 1 Promotes Cell Invasion and Stemness via Activating HIF-1α and β-Catenin Signaling Pathways in Gastric Cancer Under Hypoxia Condition
Frontiers in Oncology
doi 10.3389/fonc.2021.798557
- 2,477 views
- 4 citations
Original Research
Published on 03 Mar 2022
Prognostic Impact of Pattern of Mandibular Involvement in Gingivo-Buccal Complex Squamous Cell Carcinomas: Marrow and Mandibular Canal Staging System
Frontiers in Oncology
doi 10.3389/fonc.2021.752018
- 6,053 views
- 11 citations
Original Research
Published on 01 Mar 2022
N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma
Frontiers in Oncology
doi 10.3389/fonc.2021.726018
- 4,692 views
- 8 citations
Review
Published on 28 Feb 2022
High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics
Frontiers in Oncology
doi 10.3389/fonc.2021.811425
- 9,193 views
- 25 citations
Original Research
Published on 25 Feb 2022
Nomogram for Predicting Overall Survival and Assessing the Survival Benefit of Adjuvant Treatment in pT1-2N0M0 Triple-Negative Breast Cancer: A Surveillance, Epidemiology, and End Results-Based Study
Frontiers in Oncology
doi 10.3389/fonc.2021.663621
- 2,917 views
- 5 citations
Original Research
Published on 24 Feb 2022
A Comprehensive Risk Assessment and Stratification Model of Papillary Thyroid Carcinoma Based on the Autophagy-Related LncRNAs
Frontiers in Oncology
doi 10.3389/fonc.2021.771556
- 3,244 views
- 3 citations
Original Research
Published on 23 Feb 2022
Establishing a Macrophage Phenotypic Switch-Associated Signature-Based Risk Model for Predicting the Prognoses of Lung Adenocarcinoma
Frontiers in Oncology
doi 10.3389/fonc.2021.771988
- 3,471 views
- 2 citations
Original Research
Published on 22 Feb 2022
The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.751106
- 6,346 views
- 7 citations
Original Research
Published on 18 Feb 2022
A Composite Biomarker of Derived Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 Antibodies
Frontiers in Oncology
doi 10.3389/fonc.2021.798415
- 3,389 views
- 9 citations